Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
AZD1480 and the Hidden JAK2/STAT3 Escape Route
2026-08-24
IDO1 blockade can activate antitumor immunity while simultaneously inducing IL-6-driven, tumor-intrinsic JAK2/STAT3 survival signaling. This article positions AZD1480 as a mechanistically focused research tool for separating immune activation from adaptive tumor protection and for designing more informative translational studies.
-
AC008406.3, Cuproptosis, and Docetaxel Sensitivity
2026-08-24
A 2026 study identifies the lncRNA AC008406.3 as a suppressor of cuproptosis and a determinant of docetaxel sensitivity in breast cancer cells. Its integrated transcriptomic and experimental design links AC008406.3 inhibition with copper accumulation, loss of lipoylated and Fe–S cluster proteins, and stronger docetaxel-associated tumor suppression.
-
Angiotensin III: A Smarter RAAS Assay Strategy
2026-08-23
Angiotensin III is more than a downstream RAAS fragment: its sequence, receptor profile, and emerging spike-binding effects can reshape assay design. This guide connects peptide identity and preanalytical control with cardiovascular, neuroendocrine, and carefully bounded cross-domain research applications.
-
REV1-DHX36 Coordination at G-Quadruplex Forks
2026-08-22
A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding with suppression of replication-associated single-stranded DNA gaps. The findings define a two-tiered mechanism for G4 tolerance and clarify how REV1 loss reshapes fork progression, mutagenesis, and ATM/ATR signaling.
-
Tomivosertib: From MNK Biology to AML Assays
2026-08-22
Tomivosertib is a selective MNK1 inhibitor that enables researchers to connect eIF4E phosphorylation with leukemic-cell phenotypes. This article presents a mechanistic assay framework for separating target engagement, translational control, and downstream AML responses.
-
Zosuquidar and the Transporter Logic of PROTAC Resistance
2026-08-21
Zosuquidar (LY335979) 3HCl offers translational researchers a mechanistically grounded way to study ABCB1/P-glycoprotein-driven drug resistance. This article connects P-gp efflux pump inhibition with recent evidence that ABCB1 overexpression can create broad resistance to PROTAC degraders, while outlining practical assay design, translational limits, and opportunities for more rigorous multidrug resistance research.
-
13-Benzyl Berberine Derivatives as Antifungal Agents
2026-08-20
The 2006 study developed 13-(substituted benzyl) derivatives of berberine and berberrubine to improve activity against human pathogenic fungi. Its matched structure–activity comparison identified a 4-isopropylbenzyl berberine derivative as the most effective candidate and highlighted the importance of retaining the 9-O-methyl group for antifungal potency.
-
Vardenafil HCl Trihydrate in Proteoform Assays
2026-08-20
Use Vardenafil HCl Trihydrate to connect highly selective PDE5 inhibition with cGMP-dependent smooth muscle biology and native proteoform analysis. This workflow helps distinguish functional pathway effects from PDE6 off-target binding and assay-specific artifacts.
-
Optimizing Calcium Phosphate Transfection
2026-08-19
A 2026 study refined calcium phosphate transfection in HEK 293T cells by showing that DNA concentration must be balanced with the total reaction volume. Its reported optimum, 80 μg plasmid DNA in 1 mL for 2–3 × 105 cells/mL, provides a practical low-cost benchmark for transient gene delivery while highlighting the need for condition-specific validation.
-
M344: From HDAC Mechanism to Translational Strategy
2026-08-19
M344 illustrates how chromatin-directed pharmacology can move from biochemical potency to a rational translational program. This article examines its neuroblastoma evidence, experimental design considerations, competitive context, and opportunities for biomarker-led cancer research.
-
High-Throughput Quantification of Fractional Killing
2026-08-18
Inde, Rodencal, and Dixon present an imaging-based protocol that measures drug-induced fractional killing longitudinally rather than relying on a single viability endpoint. The workflow combines fluorescent live-cell counting with dead-cell detection and supports parallel comparison of many treatment conditions, revealing variability in MEK1/2 inhibitor responses.
-
Cell Counting Kit-8 (CCK-8): Mechanism and Use
2026-08-18
Cell Counting Kit-8 (CCK-8) is a WST-8-based cell viability measurement method for quantifying viable-cell-associated metabolic activity. Its water-soluble formazan readout supports cell proliferation assays and cytotoxicity assays without a separate solubilization step, but the signal requires biological controls and does not independently prove a molecular mechanism.
-
Minoxidil sulphate: From Channels to Translation
2026-08-17
Minoxidil sulphate is more than an active metabolite of minoxidil: it is a useful mechanistic probe for connecting potassium channel biology with vascular and follicular research. This article translates evidence from renal vascular pharmacology into practical strategies for hair growth research, alopecia research, and reproducible translational assay design.
-
12-O-tetradecanoyl phorbol-13-acetate: Lab Workflows
2026-08-17
Build reproducible ERK/MAPK pathway activation and protein kinase C signaling assays with TPA, from rapid phospho-ERK time courses to kinase and skin cancer model workflows. Practical dosing, storage, controls, and troubleshooting guidance help distinguish genuine pathway biology from handling and timing artifacts.
-
NADPH Oxidase ROS Drive Arterial Contraction
2026-08-16
This study identifies L-type voltage-gated Ca2+ channels as the principal pathway through which NADPH oxidase-derived reactive oxygen species promote contraction in saphenous arteries from early postnatal rats. Pharmacological interaction experiments separated this mechanism from Rho-kinase, PKC, and Src-kinase signaling, while ROS measurements argued against feedback activation of NADPH oxidase by L-type Ca2+ channels.